SECTORS TODAY
Tech XLK -4.89%
Financials XLF -0.76%
Healthcare XLV +0.45%
Energy XLE +1.91%
Industrials XLI -1.60%
Cons. Disc. XLY -0.71%
Cons. Staples XLP +1.41%
Utilities XLU +0.67%
Materials XLB +0.40%
Real Estate XLRE +0.26%
Comm. Svcs XLC -1.29%

Earnings release · NDSN

Nordson Corporation Reports Record Third Quarter Fiscal 2026 Results and Increases Full Year Guidance

Nordson Corp. · Filed · SEC Form 8-K, Item 2.02

Nordson Corp. company page Original on SEC.gov ↗

Revenue $818 million +10% vs a year ago
EPS $2.73 +23% vs a year ago
Guidance raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete. Please read the original before relying on any figure. Not investment advice.

Why it matters

Revenue climbed 10% year on year to $818 million, and EPS rose 23% to $2.73. Sales and earnings both ahead of a year ago is generally the cleaner kind of result. The company lifted its guidance, which is usually read as management's view of coming periods improving.

Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.

What the company states

Revenue

$818 million +10% vs a year ago

…Sales were an all-time quarterly record of $818 million, an increase of 10% year-over-year…
EPS

$2.73 +23% vs a year ago

…Earnings per diluted share were a record $2.73, up 23% year-over-year…
Guidance

Guidance raised

…Nordson Corporation Reports Record Third Quarter Fiscal 2026 Results and Increases Full Year Guidance. | Increasing full year guidance for s…

Read the original press release on SEC.gov ↗ Filing index ↗

Trend: last 1 reports

All releases →

Revenue growth (YoY)

EPS growth (YoY)

Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.

Get new research in your inbox

Forensic equity research on US stocks. No spam, unsubscribe anytime.